European Atherosclerosis Society (EAS)

The European Atherosclerosis Society’s goal is to provide a framework for concerted scientific and clinical discussion of new developments in basic research, diagnosis and therapy of atherosclerosis.

EAS is active in the publication of Guidelines and Consensus Position Papers, and its official Journal is Atherosclerosis. Through a regular series of Featured Commentaries EAS puts into perspective topical issues of relevance to our members.

The Society organizes an annual Congress for approximately 2000 delegates, and runs a programme of Advanced Courses for both basic scientists and clinicians.

EAS Academy is the Society’s online e-Learning resource, containing a range of educational material and self-teaching programmes.

EAS-Familial Hypercholesterolaemia Studies Collaboration (EAS-FHSC), formed in 2015, is generating robust information in a global registry to accurately and reliably investigate the burden of both homozygous and heterozygous FH, how FH is detected and managed, and the clinical consequences of current practices on delivery of care and outcomes.